LINC00240 in the 6p22.1 Risk Locus Promotes Gastric Cancer Progression Through USP10-mediated DDX21 Stabilization

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2023 Apr 19

PMID 37072811

Authors

Nasha Zhang

Bowen Wang

Chi Ma

Jiajia Zeng

Teng Wang

Linyu Han

Ming Yang

Affiliations

Soon will be listed here.

Abstract

Background: Gastric cancer remains the leading cause of cancer death in the world. It is increasingly evident that long non-coding RNAs (lncRNAs) transcribed from the genome-wide association studies (GWAS)-identified gastric cancer risk loci act as a key mode of cancer development and disease progression. However, the biological significance of lncRNAs at most cancer risk loci remain poorly understood.

Methods: The biological functions of LINC00240 in gastric cancer were investigated through a series of biochemical assays. Clinical implications of LINC00240 were examined in tissues from gastric cancer patients.

Results: In the present study, we identified LINC00240, which is transcribed from the 6p22.1 gastric cancer risk locus, functioning as a novel oncogene. LINC00240 exhibits the noticeably higher expression in gastric cancer specimens compared with normal tissues and its high expression levels are associated with worse survival of patients. Consistently, LINC00240 promotes malignant proliferation, migration and metastasis of gastric cancer cells in vitro and in vivo. Importantly, LINC00240 could interact and stabilize oncoprotein DDX21 via eliminating its ubiquitination by its novel deubiquitinating enzyme USP10, which, thereby, promote gastric cancer progression.

Conclusions: Taken together, our data uncovered a new paradigm on how lncRNAs control protein deubiquitylation via intensifying interactions between the target protein and its deubiquitinase. These findings highlight the potentials of lncRNAs as innovative therapeutic targets and thus lay the ground work for clinical translation.

Citing Articles

DDX21 Is a Potential Biomarker for Predicting Recurrence and Prognosis in Hepatocellular Carcinoma.

Ji C, Zhong Q, Su H, Xue X, Yang R, Li N Anal Cell Pathol (Amst). 2025; 2025:1018820.

PMID: 39866844 PMC: 11760617. DOI: 10.1155/ancp/1018820.

DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host-Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications.

Xiao Y, Fan J, Li Z, Hou Y Int J Mol Sci. 2025; 25(24.

PMID: 39769343 PMC: 11676383. DOI: 10.3390/ijms252413581.

Dysregulation of deubiquitinases in gastric cancer progression.

Xu Z, Lei Z, Peng S, Fu X, Xu Y, Pan G Front Oncol. 2024; 14:1456710.

PMID: 39605891 PMC: 11598704. DOI: 10.3389/fonc.2024.1456710.

DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation.

Ye Y, Zhang X, Wang C, Huang Y, Xu L, Liu H Cancer Cell Int. 2024; 24(1):382.

PMID: 39558224 PMC: 11575006. DOI: 10.1186/s12935-024-03567-z.

Recruitment of USP10 by GCS1 to deubiquitinate GRP78 promotes the progression of colorectal cancer via alleviating endoplasmic reticulum stress.

Chen Y, Shen H, Wang Z, Huang C, Zhang H, Shao Y J Exp Clin Cancer Res. 2024; 43(1):261.

PMID: 39267084 PMC: 11396530. DOI: 10.1186/s13046-024-03176-8.

References

Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J . A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011; 43(12):1215-8. DOI: 10.1038/ng.978. View

Lim R, Sugino T, Nolte H, Andrade J, Zimmermann B, Shi C . Deubiquitinase USP10 regulates Notch signaling in the endothelium. Science. 2019; 364(6436):188-193. DOI: 10.1126/science.aat0778. View

Guo H, Ahmed M, Zhang F, Yao C, Li S, Liang Y . Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer. Nat Genet. 2016; 48(10):1142-50. DOI: 10.1038/ng.3637. View

Wang K, Yu X, Tao B, Qu J . Downregulation of lncRNA HCP5 has inhibitory effects on gastric cancer cells by regulating DDX21 expression. Cytotechnology. 2021; 73(1):1-11. PMC: 7817730. DOI: 10.1007/s10616-020-00429-0. View

Hooi J, Lai W, Ng W, Suen M, Underwood F, Tanyingoh D . Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017; 153(2):420-429. DOI: 10.1053/j.gastro.2017.04.022. View

Hu N, Wang Z, Song X, Wei L, Kim B, Freedman N . Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours. Gut. 2015; 65(10):1611-8. PMC: 5568652. DOI: 10.1136/gutjnl-2015-309340. View

Tian J, Lou J, Cai Y, Rao M, Lu Z, Zhu Y . Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both and . Cancer Res. 2020; 80(9):1804-1818. DOI: 10.1158/0008-5472.CAN-19-2389. View

Lin Z, Yang H, Tan C, Li J, Liu Z, Quan Q . USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell Rep. 2013; 5(6):1639-49. PMC: 4007576. DOI: 10.1016/j.celrep.2013.11.029. View

He H, Li W, Liyanarachchi S, Jendrzejewski J, Srinivas M, Davuluri R . Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J Clin Endocrinol Metab. 2014; 100(1):E164-72. PMC: 4283026. DOI: 10.1210/jc.2014-2147. View

10.

Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y . Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet. 2008; 40(6):730-40. DOI: 10.1038/ng.152. View

11.

Moradi Marjaneh M, Beesley J, OMara T, Mukhopadhyay P, Koufariotis L, Kazakoff S . Non-coding RNAs underlie genetic predisposition to breast cancer. Genome Biol. 2020; 21(1):7. PMC: 6947989. DOI: 10.1186/s13059-019-1876-z. View

12.

Yuan J, Luo K, Zhang L, Cheville J, Lou Z . USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010; 140(3):384-96. PMC: 2820153. DOI: 10.1016/j.cell.2009.12.032. View

13.

Santoriello C, Sporrij A, Yang S, Flynn R, Henriques T, Dorjsuren B . RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells. Nat Cell Biol. 2020; 22(4):372-379. PMC: 7185069. DOI: 10.1038/s41556-020-0493-0. View

14.

Wang X, Xia S, Li H, Wang X, Li C, Chao Y . The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2019; 27(6):1747-1764. PMC: 7244734. DOI: 10.1038/s41418-019-0458-7. View

15.

Wang X, Ye T, Xue B, Yang M, Li R, Xu X . Mitochondrial GRIM-19 deficiency facilitates gastric cancer metastasis through oncogenic ROS-NRF2-HO-1 axis via a NRF2-HO-1 loop. Gastric Cancer. 2020; 24(1):117-132. DOI: 10.1007/s10120-020-01111-2. View

16.

Deng M, Yang X, Qin B, Liu T, Zhang H, Guo W . Deubiquitination and Activation of AMPK by USP10. Mol Cell. 2016; 61(4):614-624. PMC: 4836875. DOI: 10.1016/j.molcel.2016.01.010. View

17.

Xie J, Wen M, Zhang J, Wang Z, Wang M, Qiu Y . The Roles of RNA Helicases in DNA Damage Repair and Tumorigenesis Reveal Precision Therapeutic Strategies. Cancer Res. 2022; 82(5):872-884. DOI: 10.1158/0008-5472.CAN-21-2187. View

18.

Chen B, Dragomir M, Yang C, Li Q, Horst D, Calin G . Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022; 7(1):121. PMC: 9008121. DOI: 10.1038/s41392-022-00975-3. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Adnane S, Marino A, Leucci E . LncRNAs in human cancers: signal from noise. Trends Cell Biol. 2022; 32(7):565-573. DOI: 10.1016/j.tcb.2022.01.006. View